ContextVision AB
OSE:CONTX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.24
6.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
ContextVision AB
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 53 full-time employees. The firm's products are tailored primarily for medical imaging equipment manufacturers. Its product portfolio is structured into six groups, namely Mammography, comprising such products, as GOPView MAMMO, MAMMO PLUSViev and C-CAD; Ultrasound, comprising the US PlusView family of products, GOPView USXI and GOPiCE US products; Magnetic Resonance Imagining (MRI), comprising the GOPView MRI2 product; Computer tomography (CT), comprising the GOPView CT software; Digital X-Ray, comprising such products, as GOPView XR2 and GOPView XR2-DI, among others, and Interventional Radiology/Fluoroscopy, comprising the GOPView IRV Plus and GOPView IRV Ultra products. As of December 31, 2011, the Company had one wholly owned subsidiary, ContextVision Inc, based in the United States.
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 53 full-time employees. The firm's products are tailored primarily for medical imaging equipment manufacturers. Its product portfolio is structured into six groups, namely Mammography, comprising such products, as GOPView MAMMO, MAMMO PLUSViev and C-CAD; Ultrasound, comprising the US PlusView family of products, GOPView USXI and GOPiCE US products; Magnetic Resonance Imagining (MRI), comprising the GOPView MRI2 product; Computer tomography (CT), comprising the GOPView CT software; Digital X-Ray, comprising such products, as GOPView XR2 and GOPView XR2-DI, among others, and Interventional Radiology/Fluoroscopy, comprising the GOPView IRV Plus and GOPView IRV Ultra products. As of December 31, 2011, the Company had one wholly owned subsidiary, ContextVision Inc, based in the United States.
Revenue Drop: Q3 revenue fell to SEK 23.7 million, down 21% year-over-year, mainly due to lower license sales and continued market headwinds.
Profitability Hit: Adjusted EBITDA was SEK 4 million with a 16.7% margin, impacted by lower sales, continued R&D investments, and a non-recurring tax expense.
Cash Position: ContextVision maintains a solid cash balance of SEK 67.5 million, despite a negative cash flow in the quarter, supporting ongoing investments and a share buyback program.
Strategic Progress: Key milestones were reached in both image quality (new OEM contracts, upcoming product launch) and data quality (secured clinical study approvals).
Market Challenges: Management attributes the sales decline to broader market uncertainties, price pressure, and delayed procurements, but sees no structural customer loss.